ESR1 and breast carcinoma: From data reported by Bose et al. (2013) putative candidates seem to be identified with ER positive breast carcinomas (both ductal and lobular carcinomas analyzed), either HER2 negative (score 0/1+) or showing equivocal HER2 expression (score 2+).